ferric oxide: Clinical Trials

5 trials of ferric oxide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 2 completed, 1 enrolling by invitation. 1 Early Phase 1, 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Early Phase 11Enrolling by invitation 1
Not applicable1Completed 1
Phase 41Completed 1

Follow ferric oxide: new trials by email Literature Review of ferric oxide trials Research Report on ferric oxide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Handheld MPI Imaging to Track Stem Cells in Osteoarthritis
Human Umbilical Cord-derived Mesenchymal Stromal Cells (hUC-MSCs), Ferumoxytol (SPIO) Solution for Injection (Placebo) - Knee Arthritis Osteoarthritis
Early Phase 1Enrolling by invitationSoochow University102025-12-162026-05-12
Premarking of Axillary Nodes Before Start of Neoadjuvant Chemotherapy Using Magnetic Approach
MagTrace only, MagTrace and Magseed - Breast Cancer
Not applicableCompletedVastra Gotaland Region802021-10-012024-01-26
Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment
SLND or TAD by the magnetic technique (SPIO) - Breast Cancer, Chemotherapy Effect
Active not recruitingUppsala University1142020-01-012024-05-03
Sentinel Lymph Node Detection in Gastric Cancer Using a Dual Tracer (Superparamagnetic Iron Oxide and Methylene Blue): A Prospective Study With Histological and OSNA Validation
Dual tracer: The infiltration of the Supermagnetic Iron Oxide (SPIO) and Methylene Blue, OSNA AND H-E - Gastric Cancer (GC), Sentinel Lymph Node Biopsy (SLNB)
Active not recruitingHospital del SAS de Jerez442017-08-012025-08-29
Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma
290-400 nm sunscreen, 290-800 nm sunscreen - Melasma
Phase 4CompletedUniversidad Autonoma de San Luis Potosí682012-09-012014-12-02

Conditions studied

Breast Neoplasms (2)  ·  Melanosis (1)  ·  Stomach Neoplasms (1)

Sponsors

Hospital del SAS de Jerez (1)  ·  Soochow University (1)  ·  Universidad Autonoma de San Luis Potosí (1)  ·  Uppsala University (1)  ·  Vastra Gotaland Region (1)

Countries

Sweden (2)  ·  China (1)  ·  Mexico (1)  ·  Spain (1)

Top investigators

Andreas U Karakatsanis, MD, PhD (1)  ·  Bertha Torres-Alvarez, MD (1)  ·  Diana Hernandez-Blanco, MD (1)  ·  Fedrik Warnberg, MD PhD (1)  ·  Juan P Castanedo-Cazares, MD (1)  ·  Tuo Shao (1)